GlaxoSmithKline Pharmaceuticals Net Sales up 10%, PAT before Exceptional Items grows 12% in Third Quarter...
Mumbai, Maharashtra, India, Thursday, March 28, 2013 -- (Business Wire India) -- Dr S. Y. Quraishi , former Chief Election Commissioner (CEC) of India, has been appointed as the Honorary Chair of the Board of Trustees for Sightsavers (India).
Sightsavers is an international development organization based out of U.K with presence in more than 30 countries and works to eliminate avoidable blindness and for providing equal opportunity to persons with visual impairments.
Expressing delight at the new honour, Dr. Quraishi, soon after taking over as the Chair of Sightsavers (India) Trustee Board, said, "I feel deeply honoured on being appointed the Chair of Sightsavers in India. It also bestows immense responsibilities on me by way of the commitment to the cause of Eye healthcare and mitigation of Visual impairment. I do look forward to working with the members of the Board and its team in India."
Favorable Performance Over 2011 Periods Continues
Hawthorne, New York, United States, Tuesday, February 05, 2013 -- (Business Wire India) –
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) ("Taro" or the "Company") today provided unaudited financial results for the three and nine month periods ended December 31, 2012.
Hawthorne, New York, United States and Mumbai, Maharashtra, India, Monday, February 11, 2013 -- (Business Wire India) –
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) ("Taro") and Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries, "Sun Pharma") has announced that they have mutually agreed to terminate their merger agreement, announced in August 2012, pursuant to which all shareholders of Taro (other than Sun Pharma and its affiliates) would have received a cash payment of $39.50 per share upon the closing of the merger.